Skip to content

The Effect of Training Dietary and Fenugreek Seed in the Treatment of Diabetes

The Effect of Training Dietary Modification and Fenugreek Seed Consumption on Blood Suger and Quality of Life in Type II Diabetic Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017052233590N4
Enrollment
60
Registered
2017-06-10
Start date
2017-06-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabete. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: Intervention group 1: will receive 2 h training of nutritional advice on the basis of Iranian Traditional Medicine and Resaleh Zahabieh, consumption of fenugreek seeds 5 g twice daily
Treatment - Drugs
Placebo
Intervention group 1: will receive 2 h training of nutritional advice on the basis of Iranian Traditional Medicine and Resaleh Zahabieh, consumption of fenugreek seeds 5 g twice daily within 8 weeks.
Intervention group 2: will receive 2 h training of nutritional advice on the basis of Iranian Traditional Medicine and Resaleh Zahabieh, consumption placebo (wheat flour) 5 g twice daily within 8 week
Intervention group 3: will receive 2 h training of human anatomy, consumption of fenugreek seeds 5 g twice daily within 8 weeks.
Intervention group 4: will receive 2 h training of human anatomy, consumption of placebo (wheat flour) 5 g twice daily within 8 weeks.

Sponsors

Shahed University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: at least 6 months history of diabetes; receiving medication to control blood sugar and non-use of insulin during the study; BMI <35; age: 35 to 70 years old; not being pregnant or breastfeeding; no signs of infection (pneumonia, urinary tract infection, sepsis) that had leukocytosis, neutrophils or bandemia in tests; no history of other diseases (types of malignancies, rheumatic diseases, hormonal disorders and other specific diseases); non-use of traditional/supplementary medicine interventions. Exclusion criteria: the incidence of liver, kidney, heart, or thyroid dysfunction; inflammatory diseases and the need to take insulin during the study; pregnancy during the study; reluctance to continue the study; any intolerance of herbal products; incidence of ketoacidosis or severe hyperglycemia during study; changing the anti-diabetes drug regime during the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Fasting blood suger. Timepoint: Before the intervention, the end of the 8th week intervention. Method of measurement: Blood sample.

Secondary

MeasureTime frame
Hemoglobin A1C. Timepoint: Before the intervention, the end of the 8th week intervention. Method of measurement: Blood sample.;Quality of Life. Timepoint: Before the intervention, the end of the 8th week intervention. Method of measurement: Questionnaire 360 degree performance appraisal.;Waist. Timepoint: Before the intervention, the end of the 8th week intervention. Method of measurement: Using a tape in order to measure in cm.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyedeh Sedigheh Hassani

Shahed University

s.hassani@shahed.ac.ir+98 21 0098 2151

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026